
<ns0:uwmetadata xmlns:ns0="http://phaidra.univie.ac.at/XML/metadata/V1.0" xmlns:ns1="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0" xmlns:ns10="http://phaidra.univie.ac.at/XML/metadata/provenience/V1.0" xmlns:ns11="http://phaidra.univie.ac.at/XML/metadata/provenience/V1.0/entity" xmlns:ns12="http://phaidra.univie.ac.at/XML/metadata/digitalbook/V1.0" xmlns:ns13="http://phaidra.univie.ac.at/XML/metadata/etheses/V1.0" xmlns:ns2="http://phaidra.univie.ac.at/XML/metadata/extended/V1.0" xmlns:ns3="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/entity" xmlns:ns4="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/requirement" xmlns:ns5="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/educational" xmlns:ns6="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/annotation" xmlns:ns7="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/classification" xmlns:ns8="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/organization" xmlns:ns9="http://phaidra.univie.ac.at/XML/metadata/histkult/V1.0">
  <ns1:general>
    <ns1:identifier>o:25429</ns1:identifier>
    <ns1:title language="en">Plasma-activated medium potentiates the immunogenicity of tumor cell lysates for dendritic cell-based cancer vaccines</ns1:title>
    <ns2:alt_title language="sr">Medijum aktiviran plazmom pojačava imunogenost lizata tumorskih ćelija za vakcine protiv raka bazirane na dendritskim ćelijama</ns2:alt_title>
    <ns1:language>en</ns1:language>
    <ns1:description language="en">ABSTRACT
Autologous dendritic cells (DCs)-based vaccines are considered quite promising for cancer immunotherapy due to their exquisite potential to induce tumor antigen-specific cytotoxic T cells.
However, a lack of efficient protocols for inducing immunogenic tumor antigens limits the efficacy of DC-based cancer vaccines. Here, we found that a plasma-activated medium (PAM) induces immunogenic cell death (ICD) in tumor cells but not in an immortalized L929 cell line or human peripheral blood mononuclear cells. PAM induced an accumulation of reactive oxygen species (ROS), autophagy, apoptosis, and necrosis in a concentration-dependent manner. The tumor lysates prepared after PAM treatment displayed increased immunogenicity in a model of human monocytederived DCs, compared to the lysates prepared by a standard freezing/thawing method. Mature DCs loaded with PAM lysates showed an increased maturation potential, as estimated by their increased
expression of CD83, CD86, CD40, IL-12/IL-10 production, and attenuated PDL1 and ILT-4 expression, compared to the DCs treated with control tumor lysates. Moreover, in co-culture with allogeneic T cells, DCs loaded with PAM-lysates increased the proportion of cytotoxic IFN- + granzyme A+
CD8+ T cells and IL-17A producing T cells and preserved the Th1 response. In contrast, control tumor lysates-treated DCs increased the frequency of Th2 (CD4+IL-4+), CD4, and CD8 regulatory T cell subtypes, none of which was observed with DCs loaded with PAM-lysates. Cumulatively, these results suggest that the novel method for preparing immunogenic tumor lysates with PAM could be suitable for improved DC-based immunotherapy of cancer patients.</ns1:description>
    <ns1:keyword language="en">plasma activated medium, dendritic cells, tumor vaccines, Th polarization</ns1:keyword>
    <ns2:identifiers>
      <ns2:resource>1552099</ns2:resource>
      <ns2:identifier>10.3390/cancers13071626</ns2:identifier>
    </ns2:identifiers>
  </ns1:general>
  <ns1:lifecycle>
    <ns1:upload_date>2022-05-17T09:00:39.873Z</ns1:upload_date>
    <ns1:status>44</ns1:status>
    <ns2:peer_reviewed>yes</ns2:peer_reviewed>
    <ns1:contribute seq="0">
      <ns1:role>46</ns1:role>
      <ns1:entity seq="0">
        <ns3:firstname>Sergej</ns3:firstname>
        <ns3:lastname>Tomić</ns3:lastname>
        <ns3:institution>University of Belgrade, Institute for the Application of Nuclear Energy INEP, Serbia</ns3:institution>
        <ns3:title1>doktor bioloških nauka</ns3:title1>
        <ns3:orcid>0000-0003-2570-1295</ns3:orcid>
      </ns1:entity>
      <ns1:entity seq="1">
        <ns3:firstname>Miodrag</ns3:firstname>
        <ns3:lastname>Čolić</ns3:lastname>
        <ns3:institution>University of Belgrade, Institute for the Application of Nuclear Energy INEP, Serbia</ns3:institution>
        <ns3:title1>akademik</ns3:title1>
        <ns3:type>person</ns3:type>
      </ns1:entity>
      <ns1:entity seq="2">
        <ns3:firstname>Zoran Lj.</ns3:firstname>
        <ns3:lastname>Petrović</ns3:lastname>
        <ns3:institution>Serbian Academy for Sciences and Arts, Belgrade, Serbia</ns3:institution>
        <ns3:type>person</ns3:type>
      </ns1:entity>
      <ns1:entity seq="3">
        <ns3:firstname>Marina</ns3:firstname>
        <ns3:lastname>Bekić</ns3:lastname>
        <ns3:institution>University of Belgrade, Institute for the Application of Nuclear Energy INEP, Serbia</ns3:institution>
        <ns3:type>person</ns3:type>
        <ns3:orcid>0000-0002-6945-4241</ns3:orcid>
      </ns1:entity>
      <ns1:entity seq="4">
        <ns3:firstname>Nikola</ns3:firstname>
        <ns3:lastname>Škoro</ns3:lastname>
        <ns3:institution>University of Belgrade, Institute of Physics, Serbia</ns3:institution>
        <ns3:type>person</ns3:type>
      </ns1:entity>
      <ns1:entity seq="5">
        <ns3:firstname>Nevena</ns3:firstname>
        <ns3:lastname>Puač</ns3:lastname>
        <ns3:institution>University of Belgrade, Institute of Physics, Serbia</ns3:institution>
        <ns3:type>person</ns3:type>
      </ns1:entity>
      <ns1:entity seq="6">
        <ns3:firstname>Anđelija</ns3:firstname>
        <ns3:lastname>Petrović</ns3:lastname>
        <ns3:institution>University of Belgrade, Institute of Physics, Serbia</ns3:institution>
        <ns3:type>person</ns3:type>
      </ns1:entity>
    </ns1:contribute>
  </ns1:lifecycle>
  <ns1:technical>
    <ns1:format>application/pdf</ns1:format>
    <ns1:size>3272204</ns1:size>
    <ns1:location>https://phaidrabg.bg.ac.rs/o:25429</ns1:location>
  </ns1:technical>
  <ns1:rights>
    <ns1:cost>no</ns1:cost>
    <ns1:copyright>yes</ns1:copyright>
    <ns1:license>16</ns1:license>
  </ns1:rights>
  <ns1:classification>
    <ns1:purpose>70</ns1:purpose>
  </ns1:classification>
  <ns1:organization>
    <ns8:hoschtyp>92000001</ns8:hoschtyp>
    <ns8:orgassignment>
      <ns8:faculty>11A29</ns8:faculty>
      <ns8:department>11A2904</ns8:department>
    </ns8:orgassignment>
    <ns8:orgassignment>
      <ns8:faculty>11A23</ns8:faculty>
    </ns8:orgassignment>
  </ns1:organization>
  <ns12:digitalbook>
    <ns12:name_magazine language="en">Cancers</ns12:name_magazine>
    <ns12:volume>13</ns12:volume>
    <ns12:booklet>7</ns12:booklet>
    <ns12:releaseyear>2021</ns12:releaseyear>
  </ns12:digitalbook>
</ns0:uwmetadata>
